Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2499 of 6351
-
New spinal brace implant tracked for 5 years in teens
Disease control OngoingThe ApiFix MID-C System is a unidirectional expandable rod, designed to be connected unilaterally to the spine via 2 anchor points on the concave side of a scoliotic deformity above and below the apex of the major curvature to treat adolescent idiopathic scoliosis. The MID-C Syst…
Sponsor: Apifix • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can we predict who will benefit from immunotherapy? new study aims to find out.
Knowledge-focused OngoingThis multicenter retrospective-prospective cohort study evaluates predictive biomarker and tissue-pathology features for response to PD-1 inhibitor-based therapy in patients with squamous cell carcinoma (SCC). Model inputs include blood ELISA, tissue multiplex immunofluorescence …
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
COVID lung damage lingers months later, new study reveals
Knowledge-focused CompletedSevere Acute Respiratory Syndrome (SARS) SARS-CoV-2, name of the Coronavirus Group of international Committee on taxonomy of viruses, is an emerging virus from the family of coronaviridae, responsible for the COVID-19 pandemic. This infection can progress to viral pneumonia, and …
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Experimental T-Cell therapy targets CMV in transplant patients
Disease control Recruiting nowThe purpose of this study is to determine if a specific type of cell-based immunotherapy, using T-cells from a donor that are specific against cytomegalovirus (CMV) is feasible to treat infections by CMV. Adoptive T-cell therapy is an investigational (experimental) therapy that …
Early phase 1 • Sponsor: Mari Dallas • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Which painkiller-free method works best for teens after chest surgery?
Symptom relief OngoingPectus excavatum is the most common chest wall deformity in children, accounting for 90% of all congenital chest wall deformities. It occurs in one to eight per 1000 live births. The severity of the pectus deformity may become more noticeable during pubertal growth spurs and repa…
Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Brain zapping showdown: which target tames tremors best?
Disease control CompletedDeep brain stimulation (DBS) of both ventral intermediate nucleus (VIM) and the posterior subthalamic area (PSA) has shown to be an effective treatment for essential tremor (ET). Characterizing the differences between both targets is necessary. The aim of the study is comparison …
Sponsor: Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New MRI dye could spot hidden prostate cancer cells
Diagnosis Stopped earlyThis will be a confirmatory, prospective, open-label, single-arm, reader-blinded, multi-centre phase 3 study to assess the diagnostic accuracy and safety of Ferrotran®-enhanced MRI in comparison to unenhanced MRI in the detection of pelvic lymph node metastases in newly-diagnosed…
Phase 3 • Sponsor: Saving Patients' Lives Medical B.V. • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
Brain zaps may curb alcohol cravings, study finds
Disease control CompletedThere is growing interest in the utilization of transcranial magnetic stimulation (TMS) as a novel, non-pharmacologic approach to decreasing alcohol use among treatment-seeking individuals with Alcohol Use Disorder (AUD). The results of this study will be used to determine which …
Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
One shot to ease knee pain? new drug shows promise in large trial
Symptom relief CompletedThis phase 3 study is a multicenter, randomized, double-blind, placebo-controlled study of lorecivivint injected intraarticularly (IA) into the target knee (most painful) joint of moderately to severely symptomatic osteoarthritis (OA) subjects at a single dose of 0.07 mg lorecivi…
Phase 3 • Sponsor: Biosplice Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Pandemic's hidden toll: study screens new mothers for postpartum depression
Knowledge-focused CompletedPostpartum depression (PPD) represent around 15% of birth in developed countries. The context of the COVID-19 epidemy represents a possible source of additional emotional distress. The objective of this study is to determine the screening prevalence and risk factors of postpartum…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Scientists probe COVID-19's attack on immune cells
Knowledge-focused CompletedBackground: COVID-19 is an acute respiratory syndrome. One symptom of COVID-19 is a reduction in the number of cells called lymphocytes in the blood. Lymphocytes are a type of white blood cell that fights infections. With fewer lymphocytes, the body cannot effectively fight back…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Lung nodule biopsy showdown: which method wins?
Knowledge-focused CompletedThis study will evaluate which procedure is the best for patients referred for biopsy of a lung nodule (growth in the lung) meeting the size and location requirements of the protocol. Two different procedures are available for lung nodule biopsy: 1. a computed tomography guided …
Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New pneumonia vaccine shows promise in toddlers and infants
Vaccine CompletedPrimary objectives: * To assess the safety profile of each SP0202 formulation and Prevnar 13 in toddlers and infants (after each and any injection). * To assess the immune response (serotype specific IgG concentration) of the SP0202 formulations and Prevnar 13 1 month after the …
Phase 2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 26, 2026 15:05 UTC
-
Robots take on colon cancer surgery: a new hope for faster recovery?
Disease control Recruiting nowA single-center prospective study to elucidate whether extended robot-assisted right colectomy (e-RARC) performs as well as extended open right colectomy (e-ORC) in terms of specimen quality, and in addition, whether less postoperative morbidity and shorter length of stay (LOS) c…
Sponsor: Vejle Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Smell lost to COVID? nasal steroid rinse shows promise in trial
Symptom relief CompletedThe initial symptoms described in the first cases of COVID-19 were mainly fever and respiratory signs. Recently, there has been an increase in cases of hyposmia without associated nasal obstruction or rhinorrhea. Although we do not yet know the long-term consequences of COVID-19 …
Phase 3 • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Can a new antibody calm inflammation? a First-in-Human test begins
Knowledge-focused CompletedJS005-001 is one randomized, double-blind, placebo-controlled study to evaluate the tolerability, safety, immunogenicity and pharmacokinetic profile of single dose of JS005 injection in healthy volunteers. A total of 5 dose groups are set in the study, i.e., 15 mg, 60 mg, 150 mg…
Phase 1 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can patient records reveal who will respond to neuroendocrine tumor treatments?
Knowledge-focused CompletedMulticenter retrospective longitudinal analytical study of patients with neuroendocrine tumors.
Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Sugar pills, no lies: could Open-Placebo ease teen depression?
Symptom relief Stopped earlyMajor depressive disorder (MDD) is the current leading cause of disability worldwide and adolescence is an especially vulnerable period for the onset of depression. Non-pharmacologic approaches are particularly attractive as treatment of adolescent depression due to the elevated …
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Could a rheumatoid arthritis drug tame chronic GVHD and cut steroid use?
Disease control OngoingThis phase I trial studies the side effects of leflunomide in treating patients with steroid dependent chronic graft versus host disease (cGVHD). cGVHD is a common complication of bone marrow transplant. GVHD occurs when immune cells transplanted from a donor (the graft) recogniz…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Which rapid COVID test is more accurate? a Head-to-Head showdown
Diagnosis CancelledThis study is a comparison of the ID Now COVID-19 (Abbott) assay to the Accula SARS-CoV-2 (Mesa Biotech) assay to assist in the identification of infection with COVID-19. The tests will be compared for sensitivity, specificity, positive predictive value and negative predictive va…
Sponsor: Henry Ford Health System • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC